Sequent Asset Management’s GSK GSK Stock Holding History

Sequent Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,414	Closed	-$212K	–	69
2015 Q3	$212K	Sell	4,414 -405	-8%	-$21.1K	0.16%	68
2015 Q2	$251K	Hold	4,819	–	–	0.17%	66
2015 Q1	$278K	Sell	4,819 -7	-0.1%	-$401	0.2%	65
2014 Q4	$258K	Hold	4,826	–	–	0.19%	58
2014 Q3	$277K	Buy	4,826 +320	+7%	+$19.6K	0.21%	58
2014 Q2	$301K	Buy	+4,506	New	+$305K	0.22%	55

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sequent Asset Management's GSK Position: Q4 2015 in Review

Sequent Asset Management sold out of GSK (GSK) in Q4 2015, closing a stake of 4,414 shares — an estimated $212K sold.

Sequent Asset Management first reported a position in GSK in Q2 2014 and held it in 6 quarters. The position peaked at $301K in Q2 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Sequent Asset Management reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
Sequent Asset Management sold 4,414 GSK shares in Q4 2015, an estimated $212K.
Sequent Asset Management first reported a position in GSK in Q2 2014 and held it in 6 quarters.
Sequent Asset Management's GSK position peaked at $301K in Q2 2014.
719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Sequent Asset Management's 13F filing for Q4 2015, filed 1 Feb 2016.